Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Reneo Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RPHM
Nasdaq
8731
https://reneopharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Reneo Pharmaceuticals Inc
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
- Mar 28th, 2024 11:35 am
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
- Mar 25th, 2024 11:00 am
These Stocks under $10 Are Poised To Explode
- Dec 21st, 2023 9:13 pm
Reneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Study
- Dec 15th, 2023 3:19 pm
Why Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?
- Dec 14th, 2023 5:35 pm
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
- Dec 14th, 2023 2:05 pm
Reneo Pharmaceuticals Inc (RPHM) Reports Q3 2023 Financial Results
- Nov 13th, 2023 10:04 pm
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
- Nov 13th, 2023 12:35 pm
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
- Nov 2nd, 2023 11:50 am
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
- Oct 25th, 2023 11:50 am
12 Best Performing Biotech Stocks in 2023
- Oct 20th, 2023 5:22 pm
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
- Oct 9th, 2023 11:50 am
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
- Oct 6th, 2023 12:30 pm
Reneo Pharmaceuticals (NASDAQ:RPHM) Is In A Good Position To Deliver On Growth Plans
- Sep 20th, 2023 11:03 am
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
- Aug 10th, 2023 11:35 am
Reneo Pharmaceuticals, Inc.'s (NASDAQ:RPHM) stock price dropped 10% last week; private equity firms would not be happy
- Aug 10th, 2023 11:31 am
Bank of America Says These 2 Stocks Could Double Your Money — Here’s Why They Could Rally
- Jul 27th, 2023 3:19 pm
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
- Jun 30th, 2023 12:25 pm
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
- Jun 26th, 2023 12:25 pm
Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023
- Jun 15th, 2023 4:44 pm
Scroll